Primary Cutaneous B-Cell Non-Hodgkin Lymphoma
3 clinical trials · Condition
◉ Watch Primary Cutaneous B-Cell Non-Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma (NCT01567709) | National Cancer Institute (NCI) | 2012-04-16 |
| Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers (NCT01254578) | National Cancer Institute (NCI) | 2010-11-24 |
| Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma (NCT01000753) | Children's Oncology Group | 2005-05-30 |
Track Primary Cutaneous B-Cell Non-Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.